Key regulatory elements of the TGFβ–LRRC15 axis predict disease progression and immunotherapy resistance across cancer types
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2500524123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Michael Cheng und 19 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA. Hauptthemen laut MEDLINE: Neoplasms, Transforming Growth Factor beta, Immunotherapy, Drug Resistance, Neoplasm. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Transforming growth factor-beta (TGFβ) has dual roles in cancer, initially suppressing tumors but later promoting metastasis and immune evasion. Efforts to inhibit TGFβ have been largely unsuccessful due to significant toxicity and indiscriminate immunosuppression. Leucine-rich repeat-containing protein 15 (LRRC15) is a TGFβ-regulated antigen expressed by cancer cells of mesenchymal origin and cancer-associated fibroblasts (CAFs). In preclinical studies, ablation of TGFβ-driven LRRC15+ CAFs enhances effector functions of CD8+ T cells. However, the pathobiological mechanisms associated with TGFβ’s upregulation of LRRC15 expression in cancer cells remain unclear. Using an integrated approach combining functional compound screening with scRNA-seq, we reveal key genomic features regulating TGFβ’s ability to increase LRRC15 expression on cancer cells. Construction of gene regulatory networks converged our analyses on four key genes ( MMP2, SPARC, TGFβR2, and WNT5B ) central to TGFβ-induced LRRC15 pathobiology in cancer cells. Validation of these genes in cell models and their use in predicting immunotherapy responses highlight their potential in refining immunotherapy strategies and personalizing cotreatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA.
- Department of Integrative Biology & Physiology, University of California Los Angeles, Los Angeles, CA.
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA.
- Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Lund University Cancer Centre, Lund University, Lund, Sweden.
- German Cancer Consortium (DKTK), partner site Essen, a partnership between German Cancer Research Center (DKFZ) and University Hospital Essen, Essen, Germany.
ORCID-Profile: Michael Cheng, Claire M Storey, Julie Tran, Daniel Thorek, Liqun Mao, Wahed Zedan, Constance Yuen, Ken Herrmann, Bilal A Siddiqui, Jens T Siveke, Xia Yang, David Ulmert
Zitieren
APA
Cheng, M., Storey, C. M., Altai, M., Park, J. E., Tran, J., Lueong, S. S., Thorek, D., Mao, L., Zedan, W., Yuen, C., Ridley, A., Trajkovic-Arsic, M., Herrmann, K., Subudhi, S. K., Siddiqui, B. A., Lückerath, K., Siveke, J. T., Damoiseaux, R., Yang, X., & Ulmert, D. (2026). Key regulatory elements of the TGFβ–LRRC15 axis predict disease progression and immunotherapy resistance across cancer types. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2500524123
Vancouver
Cheng M, Storey CM, Altai M, Park JE, Tran J, Lueong SS, et al. Key regulatory elements of the TGFβ–LRRC15 axis predict disease progression and immunotherapy resistance across cancer types. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2500524123
BibTeX
@article{Cheng2026,
author = {Cheng, Michael and Storey, Claire M and Altai, Mohamed and Park, Julie E and Tran, Julie and Lueong, Smiths S and Thorek, Daniel and Mao, Liqun and Zedan, Wahed and Yuen, Constance and Ridley, Alexander and Trajkovic-Arsic, Marija and Herrmann, Ken and Subudhi, Sumit K and Siddiqui, Bilal A and Lückerath, Katharina and Siveke, Jens T and Damoiseaux, Robert and Yang, Xia and Ulmert, David},
title = {Key regulatory elements of the TGFβ–LRRC15 axis predict disease progression and immunotherapy resistance across cancer types},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2500524123}
}
EUVIMED